India  

Serum Institute of India faces legal notice, to file Rs.100 Cr case against volunteer|Oneindia News

Video Credit: Oneindia - Duration: 01:16s - Published
Serum Institute of India faces legal notice, to file Rs.100 Cr case against volunteer|Oneindia News

Serum Institute of India faces legal notice, to file Rs.100 Cr case against volunteer|Oneindia News

After a Covidshield Coronavirus vaccine trial participant claimed that he suffered from a virtual neurological breakdown after being administered a dose, The Serum Institute of India has reacted sharply, dismissing the allegations as malicious and misconceived.

It has said that it will file a Rs.100 Crore defamation suit against the Participant.

Serum Institute has said that while it sympathised with the volunteer's medical condition there was absolutely no correlation with the vaccine trial and the medical condition of the volunteer.

#SerumInstituteOfIndia #CovidshieldVaccine #Coronavirus


You Might Like

Related news from verified sources

Serum Institute files Rs 100 crore defamation case after man says vaccine left him ill

After a Chennai-based volunteer served a legal notice to the Serum Institute of India (SII) demanding...
Mid-Day - Published


Related videos from verified sources

Covid-19: PM Modi interacts with 3 teams working on vaccine development [Video]

Covid-19: PM Modi interacts with 3 teams working on vaccine development

Prime Minister Narendra Modi interacted with three teams working on developing and manufacturing of vaccines against Covid-19. The teams were from Gennova Biopharmaceuticals Ltd, Biological E Ltd, and..

Credit: HT Digital Content     Duration: 01:15Published
Covid-19 vaccine to be distributed initially in India says Serum Institute CEO [Video]

Covid-19 vaccine to be distributed initially in India says Serum Institute CEO

The CEO of India's Serum Institute says India will get supplies of the Oxford-AstraZeneca vaccine that his organisation produces, first.

Credit: Newsflare STUDIO     Duration: 01:28Published
‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla [Video]

‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla

Serum Institute India CEO Adar Poonawalla spoke on Prime Minister Narendra Modi’s visit to vaccine lab in Pune. Poonawalla said that he was amazed by the Prime Minister's knowledge about vaccines and..

Credit: HT Digital Content     Duration: 04:05Published